Open-label, single-arm, non-controlled trial to evaluate the safety and tolerability of treprostinil sodium in children below the age of 18 years with pulmonary arterial hypertension (PAH)]

• Protocol code: TREPaed
• EudraCT code: No aplica
• Research group: Growth and Development
• Service: General Pediatrics and Specialties
• Principal investigator:  Moreno Galdó, Antonio
• Pathology: Malalties del sistema respiratori
• Phase: Fase III